GlassScriptPhysician profile
Paul R Eber
NPI 1124085634
$476,064.93
in general payments reported to CMS, 2019-2025
60 companies · $71K in 2025
The $71K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $40K · 2021: $46K · 2022: $101K · 2023: $95K · 2024: $56K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $176K · Travel and Lodging: $24K · Food and Beverage: $8,955 · Consulting Fee: $8,789 · Honoraria: $4,080 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $176,134.43 |
| Travel and Lodging | $24,102.73 |
| Food and Beverage | $8,954.84 |
| Consulting Fee | $8,788.85 |
| Honoraria | $4,080.00 |
| Education | $178.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $124,278.41 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $117,615.88 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $94,358.62 | 2019-2025 | |
| Janssen Biotech, INC. | $68,642.03 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Pfizer INC. | $33,071.99 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $19,134.76 | 2020-2025 | Lynparza, Imfinzi |
| Urogen Pharma, INC. | $5,476.91 | 2020-2025 | |
| Avyxa Pharma, LLC | $3,370.70 | 2025 | |
| Janssen Scientific Affairs, LLC | $2,074.29 | 2022-2025 | Erleada, Akeega |
| Exelixis INC. | $1,470.00 | 2021 | |
| Sumitomo Pharma America, INC. | $903.97 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $584.67 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $475.52 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $445.25 | 2020-2025 | Botox, Lupron Depot |
| Novartis Pharmaceuticals Corporation | $417.77 | 2020-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $394.46 | 2019-2025 | Adstiladrin |
| Amgen INC. | $312.13 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $248.91 | 2019-2025 | Yonsa |
| Myovant Sciences INC. | $244.93 | 2021-2022 | |
| Boston Scientific Corporation | $231.90 | 2020-2022 | |
| Teleflex LLC | $206.09 | 2024-2025 | Barrigel |
| Allergan, INC. | $182.28 | 2019-2022 | |
| Medtronic USA, INC. | $159.52 | 2020 | |
| Angiodynamics, INC. | $151.40 | 2024 | Nanoknife |
| I/O Urology Corp. | $149.83 | 2024 | Carepath |
| Verity Pharmaceuticals INC. | $131.86 | 2022-2024 | Trelstar, Tlando |
| Calyxo, INC. | $125.93 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $112.87 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $104.36 | 2022-2024 | Prolaris |
| Progenics Pharmaceuticals, INC. | $97.76 | 2023 | Pylarify |
| Telix Pharmaceuticals | $81.47 | 2024-2025 | Illuccix |
| Accord Healthcare, INC. | $76.24 | 2025 | |
| Axonics, INC. | $64.27 | 2020-2024 | Bulkamid |
| Tolmar, INC. | $62.64 | 2023-2025 | Eligard, Jatenzo |
| Intuitive Surgical, INC. | $52.30 | 2024 | |
| Laborie Medical Technologies Corp. | $52.19 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $48.65 | 2022 | |
| Antares Pharma, INC. | $48.38 | 2019-2024 | Xyosted |
| Mission Pharmacal Company | $35.25 | 2019-2020 | |
| Procept Biorobotics Corporation | $32.47 | 2024 | Aquabeam System |
| Avadel Specialty Pharmaceuticals, LLC | $26.04 | 2019 | |
| Conmed Corporation | $25.25 | 2024 | Airseal |
| Medtronic, INC. | $24.12 | 2023 | Signia |
| Endo USA, INC. | $23.17 | 2024 | Xiaflex |
| Travere Therapeutics, INC. | $21.72 | 2021 | |
| Davol INC. | $21.06 | 2024 | Arista Ah Flexitip |
| Clarus Therapeutics INC. | $20.96 | 2021 | |
| Hollister Incorporated | $18.47 | 2024 | |
| Abc Home Medical Supply, INC. | $18.47 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $17.80 | 2024 | |
| Tempus Ai, INC | $16.01 | 2024 | Xt Cdx |
| Foundation Medicine, INC. | $15.81 | 2023 | |
| Therapeuticsmd, INC. | $14.94 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $14.49 | 2020 | |
| Sandoz INC. | $14.33 | 2025 | Jubbonti, Wyost |
| Ambu INC. | $12.61 | 2020 | |
| Coloplast Corp | $12.38 | 2021 | |
| Valencia Technologies Corporation | $9.90 | 2025 | Ecoin Device Kit |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Eber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.